摘要
β-淀粉样蛋白(Aβ)、神经毒性的多肽,蓄积在阿耳茨海默氏病(AD)患者的脑部,最初引发神经炎症最终导致记忆障碍。在这里,我们证明了与假手术大鼠相比,Aβ注射的大鼠表现出认知功能障碍和神经炎症和海马区硫化氢(H2S)的水平的显着减少。有趣的是,胱硫醚β合酶(CBS)和3- mercaptopyruvate-sulfurtransferase(3MST)(负责内源性硫化氢产生的主要的酶)的表达也显著减少。但是,注射10微克Aβ1-42将导致腹膜内(IP)注射硫氢化钠(硫氢化钠,硫化氢一个供体)大大减弱了,大鼠海马认知功能障碍和神经炎症。随后,在Aβ给药后,硫氢化钠显著抑制大鼠海马的肿瘤坏死因子(TNF)-α,白细胞介素1β(IL-1β)和环氧合酶-2(COX-2)的表达。此外,硫氢化钠发挥了抑制IκB-α降解和转录因子核因子κB的随后活化(NF-κB),以及抑制细胞外信号调节激酶(ERK1 / 2)的活性和p38蛋白活性的有益效果,但C-Jun N末端激酶(JNK)的活性没有受到Aβ影响。这些结果表明,硫氢化钠是可能用于治疗神经炎症相关AD的潜在试剂。
关键词: 3- mercaptopyruvate-sulfurtransferase(3MST),阿耳茨海默氏病,β-amyloid1-42,胱硫醚β合酶(CBS),硫化氢,神经炎症。
Current Alzheimer Research
Title:Sodium Hydrosulfide Attenuates Beta-Amyloid-Induced Cognitive Deficits and Neuroinflammation via Modulation of MAPK/NF-κB Pathway in Rats
Volume: 12 Issue: 7
Author(s): Huiyu Liu, Yuanyuan Deng, Jianmei Gao, Yuangui Liu, Wenxian li, Jingshan Shi and Qihai Gong
Affiliation:
关键词: 3- mercaptopyruvate-sulfurtransferase(3MST),阿耳茨海默氏病,β-amyloid1-42,胱硫醚β合酶(CBS),硫化氢,神经炎症。
摘要: Beta-amyloid (Aβ), a neurotoxic peptide, accumulates in the brain of Alzheimer's disease (AD) subjects to initiate neuroinflammation eventually leading to memory impairment. Here, we demonstrated that Aβ-injected rats exhibited cognitive impairment and neuroinflammation with a remarkable reduction of hydrogen sulfide (H2S) levels in the hippocampus compared with that in shamoperated rats. Interestingly, the expression of cystathionine-β-synthase (CBS) and 3- mercaptopyruvate-sulfurtransferase (3MST), the major enzymes responsible for endogenous H2S generation, were also significantly decreased. However, intraperitoneal (i.p.) injection of sodium hydrosulfide (NaHS, a H2S donor) dramatically attenuated cognitive impairment and neuroinflammation induced by hippocampal injection of 10 μg of Aβ1-42 in rats. Subsequently, NaHS significantly suppressed the expression of tumor necrosis factor (TNF)-α, interleukin-1β (IL-1β) and cyclooxygenase-2 (COX-2) in rat hippocampus following Aβ administration. Furthermore, NaHS exerted a beneficial effect on inhibition of IκB-α degradation and subsequent activation of transcription factor nuclear factor κB (NF-κB), as well as inhibition of extracellular signal-regulated kinase (ERK1/2) activity and p38 MAPK activity but not c-Jun N-terminal kinase (JNK) activity induced by Aβ. These results demonstrate that NaHS might be a potential agent for treatment of neuroinflammation-related AD.
Export Options
About this article
Cite this article as:
Huiyu Liu, Yuanyuan Deng, Jianmei Gao, Yuangui Liu, Wenxian li, Jingshan Shi and Qihai Gong , Sodium Hydrosulfide Attenuates Beta-Amyloid-Induced Cognitive Deficits and Neuroinflammation via Modulation of MAPK/NF-κB Pathway in Rats, Current Alzheimer Research 2015; 12 (7) . https://dx.doi.org/10.2174/1567205012666150713102326
DOI https://dx.doi.org/10.2174/1567205012666150713102326 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mesalamine for Inflammatory Bowel Disease: Recent Reappraisals
Inflammation & Allergy - Drug Targets (Discontinued) Research Advances of Endostatin and its Short Internal Fragments
Current Protein & Peptide Science Early Diagnosis of Multiple Sclerosis Based on Optical and Electrochemical Biosensors: Comprehensive Perspective
Current Analytical Chemistry Inflammation, Serotonin and Major Depression
Current Drug Targets Thalidomide and Analogs as Anti-Inflammatory and Immunomodulator Drug Candidates
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nutraceuticals and Dietary Supplements to Improve Quality of Life and Outcomes in Heart Failure Patients
Current Pharmaceutical Design A Systematic Review of a Naturally Occurring Iridoid: Catalpol
Current Bioactive Compounds Targeting of Low-Molecular Weight Drugs to Mammalian Mitochondria
Drug Design Reviews - Online (Discontinued) RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease
Current Medicinal Chemistry COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases
Current Rheumatology Reviews Introduction to Molecular Topology: Basic Concepts and Application to Drug Design
Current Computer-Aided Drug Design Patents in the Diagnosis and Therapy of Neurocardiogenic Syncope
Recent Patents on Cardiovascular Drug Discovery Pathophysiological Role of Proteasome-Dependent Proteolytic Pathway in Endothelin-1-Related Cardiovascular Diseases
Current Vascular Pharmacology Metabolic Profiling in Disease Diagnosis, Toxicology and Personalized Healthcare
Current Pharmaceutical Biotechnology Metalloproteinase-Mediated Shedding of Heparin-Binding Egf-Like Growth Factor and Its Pathophysiological Roles
Protein & Peptide Letters Synthesis of 2-Thiohydantoins as Somatostatin Subtype 4 Receptor Ligands
Letters in Drug Design & Discovery Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index
Current Pharmaceutical Design Dendritic Cell-Based Therapies in the Bench and the Bedsides
Current Drug Targets - Inflammation & Allergy Cell Immunity in Coronary Artery Disease (CAD)
Current Immunology Reviews (Discontinued) Role of Statins in Peri-Operative Medicine
Current Drug Targets